FAT Company Profile

Extremely pressing financial reporting period for Aeva Technologies Inc over the financial fourth quarter of 2022

Aeva Technologies Inc declared disastrous fourth quarter of 2022 financial report, where Sales faded by -93.456 % to $0.19 millions and net loss per share has extended to $-0.19, from the corresponding financial reporting period a year prior.

For the fourth quarter of 2022 company reached 0 of $0.00 per share compare to $-0.15 a year prior and from $-0.48 per share from the preceding reporting period.

Sales remained unaltered to $0.00 millions from $2.87 millions in the comparable reporting period a year prior and sequentially Sales Tumbled from $0.00 millions.

Recreational Products company, decline in the operating results all over most recent fiscal period

The stockholders have not anticipated some adjustments at the revenue all over the November to January 31 2023 reporting cycle at the company. Yet, they pay near attention to QSMGs' operating loss that has been at $-0.038748 millions, in the same period.

The Specialty Retail company disclosed that Sales have improved significantly, during the fiscal period ending January 28 2023

Regardless of notable Sales growth of 294.53 % year on year to $441.16 millions in the fiscal period ending January 28 2023, HIBBs' income turned positive at $4.04.

For the most recent fiscal period Leap Therapeutics Inc decreased a loss per share of $-0.08 per share compare to $-0.10 a year before and earnings per share improved from $-0.13 per share from the prior quarter.

Sales remained unchanged to $0.00 millions from $0.38 millions in the similar quarter a year before and sequentially Sales increased from $0.00 millions.